Discontinuation report BRILINTA
| Report ID | 257178 |
| Drug Identification Number | 02368544 |
| Brand name | BRILINTA |
| Common or Proper name | TICAGRELOR |
| Company Name | ASTRAZENECA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TICAGRELOR |
| Strength(s) | 90MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 30 tabs |
| ATC code | B01AC |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2025-11-15 |
| Actual discontinuation date | |
| Remaining supply date | 2025-10-15 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | asdf 12345 |
| Company comments | asdf 12345 |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: [email protected]. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-08-07 | French | Compare |
| v3 | 2025-08-07 | English | Compare |
| v2 | 2025-08-07 | French | Compare |
| v1 | 2025-08-07 | English | Compare |
Showing 1 to 4 of 4